Literature DB >> 25863560

Tuberculosis and vitamin D: what's the rest of the story?

Peter Cegielski1, Andrew Vernon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25863560      PMCID： PMC4696485          DOI： 10.1016/S1473-3099(15)70163-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  14 in total

Review 1.  Nutritional supplements for people being treated for active tuberculosis.

Authors:  David Sinclair; Katharine Abba; Liesl Grobler; Thambu D Sudarsanam
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  Vitamin D and The Magic Mountain: the anti-infectious role of the vitamin.

Authors:  Russell W Chesney
Journal:  J Pediatr       Date:  2010-05       Impact factor: 4.406

3.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

Review 4.  New insights into the interaction of Mycobacterium tuberculosis and human macrophages.

Authors:  Heiko Bruns; Steffen Stenger
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

5.  Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.

Authors:  Rakesh Lodha; Aparna Mukherjee; Varinder Singh; Sarman Singh; Henrik Friis; Daniel Faurholt-Jepsen; Shinjini Bhatnagar; Savita Saini; Sushil K Kabra; Harleen M S Grewal
Journal:  Am J Clin Nutr       Date:  2014-09-10       Impact factor: 7.045

6.  Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.

Authors:  Peter Daley; Vijayakumar Jagannathan; K R John; Joy Sarojini; Asha Latha; Reinhold Vieth; Shirly Suzana; Lakshmanan Jeyaseelan; Devasahayam J Christopher; Marek Smieja; Dilip Mathai
Journal:  Lancet Infect Dis       Date:  2015-04-08       Impact factor: 25.071

7.  Vitamin D and the immune system: new perspectives on an old theme.

Authors:  Martin Hewison
Journal:  Rheum Dis Clin North Am       Date:  2012-04-12       Impact factor: 2.670

Review 8.  The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals.

Authors:  J P Cegielski; D N McMurray
Journal:  Int J Tuberc Lung Dis       Date:  2004-03       Impact factor: 2.373

9.  1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.

Authors:  A K Bhalla; E P Amento; B Serog; L H Glimcher
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

10.  Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.

Authors:  Anna K Coussens; Robert J Wilkinson; Yasmeen Hanifa; Vladyslav Nikolayevskyy; Paul T Elkington; Kamrul Islam; Peter M Timms; Timothy R Venton; Graham H Bothamley; Geoffrey E Packe; Mathina Darmalingam; Robert N Davidson; Heather J Milburn; Lucy V Baker; Richard D Barker; Charles A Mein; Leena Bhaw-Rosun; Rosamond Nuamah; Douglas B Young; Francis A Drobniewski; Christopher J Griffiths; Adrian R Martineau
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205
View more
  5 in total

1.  Prevalence and clinical impact of vitamin D deficiency on abdominal tuberculosis.

Authors:  Vishal Sharma; Harshal S Mandavdhare; Amit Kumar; Ravi Sharma; Naresh Sachdeva; Kaushal K Prasad; Surinder S Rana
Journal:  Ther Adv Infect Dis       Date:  2017-05-25

2.  Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia.

Authors:  A Bekele; N Gebreselassie; S Ashenafi; E Kassa; G Aseffa; W Amogne; M Getachew; A Aseffa; A Worku; R Raqib; B Agerberth; U Hammar; P Bergman; G Aderaye; J Andersson; S Brighenti
Journal:  J Intern Med       Date:  2018-05-23       Impact factor: 8.989

3.  Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.

Authors:  Matthew J Magee; Yan V Sun; James C M Brust; N Sarita Shah; Yuming Ning; Salim Allana; Angela Campbell; Qin Hui; Koleka Mlisana; Pravi Moodley; Neel R Gandhi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 4.  Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations.

Authors:  Rihwa Choi; Byeong Ho Jeong; Won Jung Koh; Soo Youn Lee
Journal:  Ann Lab Med       Date:  2017-03       Impact factor: 3.464

Review 5.  The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.

Authors:  Helder Novais Bastos; Nuno S Osório; Sebastien Gagneux; Iñaki Comas; Margarida Saraiva
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.